Factors Influencing the Adoption of User-Administered Injectable Contraceptives in the United States
January 9, 2026
Brand Name :
N/A
Synonyms :
Impacarzinum
Class :
Antiviral agent
Action and Spectrum
Impacarzine has anti-viral properties to fight against the viral infections.
Limited data is available
Limited data is available
Contraindication/Caution:
Contraindications
Cautions
Pregnancy consideration:
No data is available regarding the administration of the drug during pregnancy.
Breastfeeding warnings:
No data is available regarding the excretion of drug in breast milk.
Pregnancy categories:
Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester.
<b>Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: No data is available for the drug under this category.
Pharmacology
Not much data available on the pharmacology
Pharmacodynamics
Not much data available on the pharmacodynamics
Pharmacokinetics
Limited data is available on the ADME
Administration
The route of administration is oral
Patient information leaflet
Generic Name: impacarzine
Pronounced: im-puh-KAR-zeen
Why do we use impacarzine?
Impacarzie has anti-viral activity to fight against the viral infections.